Disphanurat W, Srisantithum B. Efficacy and Safety of 0.15% Isobutylamido Thiazolyl Resorcinol Combined with Hyaluronic Acid versus 0.15% Isobutylamido Thiazolyl Resorcinol or Hyaluronic Acid Alone in Melasma Treatment: A randomized Evaluator-blind Trial. AMJAM [Internet]. 2022 Aug. 1 [cited 2024 Nov. 24];22(-):S117. Available from: https://asianmedjam.com/index.php/amjam/article/view/1287